Cargando…
On the nature of cancer and why anticancer vaccines don't work
In this essay I suggest that the major difficulty in producing effective anti-cancer vaccines lies in the fact that most cancers have little immunogenicity because of a basic paucity of tumor-specific antigenicity. The lack of antigenicity, despite extensive genomic instability, could be explained i...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1185554/ https://www.ncbi.nlm.nih.gov/pubmed/16060965 http://dx.doi.org/10.1186/1475-2867-5-25 |
_version_ | 1782124739314057216 |
---|---|
author | Prehn, Richmond T |
author_facet | Prehn, Richmond T |
author_sort | Prehn, Richmond T |
collection | PubMed |
description | In this essay I suggest that the major difficulty in producing effective anti-cancer vaccines lies in the fact that most cancers have little immunogenicity because of a basic paucity of tumor-specific antigenicity. The lack of antigenicity, despite extensive genomic instability, could be explained if most tumor mutations occur in silenced genes. A further problem is that an immune reaction against tumor antigens, especially in moderate or low amount, may be stimulatory rather than inhibitory to tumor growth. |
format | Text |
id | pubmed-1185554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-11855542005-08-13 On the nature of cancer and why anticancer vaccines don't work Prehn, Richmond T Cancer Cell Int Hypothesis In this essay I suggest that the major difficulty in producing effective anti-cancer vaccines lies in the fact that most cancers have little immunogenicity because of a basic paucity of tumor-specific antigenicity. The lack of antigenicity, despite extensive genomic instability, could be explained if most tumor mutations occur in silenced genes. A further problem is that an immune reaction against tumor antigens, especially in moderate or low amount, may be stimulatory rather than inhibitory to tumor growth. BioMed Central 2005-08-01 /pmc/articles/PMC1185554/ /pubmed/16060965 http://dx.doi.org/10.1186/1475-2867-5-25 Text en Copyright © 2005 Prehn; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Hypothesis Prehn, Richmond T On the nature of cancer and why anticancer vaccines don't work |
title | On the nature of cancer and why anticancer vaccines don't work |
title_full | On the nature of cancer and why anticancer vaccines don't work |
title_fullStr | On the nature of cancer and why anticancer vaccines don't work |
title_full_unstemmed | On the nature of cancer and why anticancer vaccines don't work |
title_short | On the nature of cancer and why anticancer vaccines don't work |
title_sort | on the nature of cancer and why anticancer vaccines don't work |
topic | Hypothesis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1185554/ https://www.ncbi.nlm.nih.gov/pubmed/16060965 http://dx.doi.org/10.1186/1475-2867-5-25 |
work_keys_str_mv | AT prehnrichmondt onthenatureofcancerandwhyanticancervaccinesdontwork |